This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB07306/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07306/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07306/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07306/identifier/chemspider/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07306/identifier/pdb/

Statements

Subject Item
n2:DB07306
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB07306 n12:DB07306
dcterms:title
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
adms:identifier
n6:DB07306 n9:A11 n11:24605321 n13:24894151 n14:99443777
n3:IUPAC-Name
n4:271B5E6E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5E74-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5E73-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5E70-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5E71-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5E72-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5E6C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5E6A-363D-11E5-9242-09173F13E4C5 n4:271B5E6D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5E6B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5E7A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5E7B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5E75-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5E76-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5E78-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5E77-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5E79-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5E7F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5E81-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5E82-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5E7E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5E7D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5E80-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5E6F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5E7C-363D-11E5-9242-09173F13E4C5